NEW NANOTHERAPY RESEARCH FOR INFLAMMATORY BOWEL DISEASES
THE NEW DEAL CONCEPT COULD REVOLUTIONIZE IBD THERAPIES FOR THE GREAT BENEFIT OF PATIENTS AND EUROPEAN HEALTHCARE SYSTEMS.
- Dr. Fabrice NAVARRO, New Deal Project Coordinator
THE PROJECT GOALS
THE PROJECT GOALS
The NEW DEAL project aims to develop a highly selective and local therapy with an improved efficacy and safety profile for IBD patients. This treatment might be an alternative to the existing therapies.
Design and validate a radically improved IBD therapy that specifically targets JAK1 / JAK3 inhibition by means of siRNA and RNAi interference.
Develop advanced technologies for delivering siJAK1 / siJAK3 locally to the inflamed gut
Promote the clinical translation and the future industrial transfer of this new clinical product for IBD therapy.
THE PROJECT NEWS
Let’s talk about it: The gut-brain dialogue, third edition of our IBD&Tea event
In our busy and fast world, mental health is becoming more and more important. Our emotional, psychological and [...]
February New Deal Reads
Oral nanoparticles of SNX10-shRNA plasmids ameliorate Mouse Colitis. W.Bao, Q.Wu, B.Hu, D.Sun, S.Zhao, X.Shen, H.Cheng & W.Shen. Int [...]
January New Deal Reads
Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy. [...]
IBD & Tea: what patients want to know when it comes to a clinical trial
Often, patients who live with Inflammatory Bowel Disease (IBD) do not respond to conventional drugs and are offered [...]
THE PROJECT PARTNERS
THE PROJECT PARTNERS
